AmerisourceBergen Reprimanded for Ineffective Suspicious Order Monitoring The settlement between the California Board of Pharmacy and AmerisourceBergen demonstrates the importance of embracing Suspicious Order Monitoring as a systematic and procedural Background The...
How Telemedicine Has Made Generic Drugs Sexy Since 2017, Direct-to-Consumer (DTC) startups (some engaged by Pharma Solutions!) have cropped up to market and supply drugs to patients across the United States. The product portfolio is not too exciting – including...
DEA SOM 2020 Updates Over two years in the making, the light at the end of the tunnel might finally be in sight – the Drug Enforcement Administration’s (DEA) has issued a Notice for Proposed Rule making as an update to the infamous definition of a “suspicious...
Consolidation is on the Horizon for 503Bs and WDDs The pharmaceutical industry has been notorious for consolidation and vertical integration over the last decade – and we can now expect another wave across two different business models. 503B Most of the content...
Pending Regulation on Drug Pricing Bernie Sanders and other top Democrats have made drug pricing a hot topic in US politics, especially with the election coming up next year. As such, there has been a flurry of bills and solutions to the perceived problem – and Drug...
